Importantly, our findings reveal cellular processes that modify radioiodide uptake outside of the canonical pathways of NIS processing, leading to an improved mechanistic understanding of endogenous NIS function, which is subverted in cancer, as well as facilitating the identification of key target genes to construct an independent predictive risk model of recurrent thyroid cancer. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.